Results

Total Results: 783 records

Showing results for "therapy".

461. Screening for Gestational Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/9K4QQKvhXZNJLCxNX3FkZm
     May 01, 2008 - There was fair to good evidence that screening, combined with therapy for gestational diabetes, Clinical … In contrast, the ACHOIS participants used insulin only if other therapies failed to achieve tight glycemic … and no worse with alternate therapies. … With regard to potential fetal or newborn risks, the potential teratogenicity of certain newer treatments … ; how- ever, most treatments for gestational diabetes start in the second trimester, after the period

462. Final Research Plan: Vision in Children Ages 6 Months to 5 Years: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vision-in-children-ages-6-months-to-5-years-screening
     December 17, 2015 - For children with amblyopia, its risk factors, or refractive error, treatment may improve health outcomes … Treatment may also result in harms (key question 5). … Does treatment of amblyopia, its risk factors, and refractive error in children ages 6 months to 5 years … What are the harms of treatment of amblyopia, its risk factors, and refractive error in children ages … refractive error (eyeglasses); penalization of the nonamblyogenic eye (eye patch, atropine); and vision therapy

463. Second Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2012%20(2).pdf
     November 01, 2012 - cascade of additional follow-up tests (some of which are invasive and could cause harm) and unnecessary treatments … Potential harms also include side effects or complications of treatments. … (Grade: D) This recommendation applies to postmenopausal women who are considering hormone therapy … Screening and Treatment for Depression in Children 3. … Curry’s health service research has focused on the use and cost effectiveness of tobacco cessation treatments

464. untitled (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/y_ApQN4Tw4RtnoWWrofH8d
     December 20, 2016 - Grade: D Screening Tests Treatment and Interventions Balance of Benefits and Harms Other Relevant … The evidence is inadequate to de- termine if suppressive antiviral therapy reduces transmission of genital … No studies have examined the effectiveness of antiviral therapy to decrease the risk for HSV transmission … The CDC recom- mends that women with recurrent genital herpes during pregnancy be offered suppressive therapy … Sexually Transmitted Infections: Diagnosis, Management, and Treatment.

465. Archived: Final Research Plan: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/falls-prevention-in-older-adults-interventions-2018
     October 22, 2015 - ) Surgery (e.g., cataract extraction, pacemaker placement, podiatry surgery) Fluid or nutrition therapy … In terms of included interventions, the USPSTF clarified that vision and hearing screening and treatment

466. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/g2bEcQW6ae_NTFZ9KUxT_t
     August 24, 2021 - • More US data are needed on the effects of lifestyle interventions and medical treatments for screen-detected … Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with … A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on … Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes … Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the

467. Final Research Plan: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vitamin-d-calcium-or-combined-supplementation-for-the-primary-prevention-of-fractures-in-adults-preventive-medication
     June 23, 2016 - or other medications associated with osteoporosis (e.g., aromatase inhibitors, androgen deprivation therapy … obtained through natural or artificial ultraviolet light exposure Comparison Placebo, no treatment … harms of vitamin D and calcium supplementation in persons who are not already identified as needing treatment

468. Archived: Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-september-2015
     September 21, 2015 - Nicotine replacement therapy is a pregnancy category D medication, which means that there is positive … Although no ENDS manufacturer has applied to the FDA to have its product approved as a therapeutic device … fair-quality systematic reviews on behavioral interventions, including complementary or alternative therapies … Nicotine replacement therapy for smoking cessation. … Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation.

469. Ninth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-annual-report-to-congress-2019.pdf
     January 01, 2019 - The National Institute of Mental Health works every day to transform the understanding and treatment … Considerations for Implementation: To determine whether a patient is a candidate for statin therapy, … Considerations for Implementation: To determine whether a patient is a candidate for statin therapy, … D Hormone Therapy With Combined Estrogen and Progestin in Postmenopausal Women: Primary Prevention … Considerations for Implementation: To determine whether a patient is a candidate for statin therapy,

470. Screening for Syphilis: A Brief Update (pdf file)
     www.uspreventiveservicestaskforce.org/USPSTF_Admin/Home/GetFile/1/996/syphilup/pdf
     July 01, 2004 - are effective and rarely harmful, and prenatal antibiotic therapy is effective in preventing congenital … reported that ceftriaxone is used clinically for treating syphilis in the U.S.36 Value of augmented therapy … A multicenter RCT assessed 2 treatments for early syphilis: both groups received 2.4 million units of … A number of small studies on alternative treatments such as oral azithromycin have been published and … A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency

471. Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/impaired-visual-acuity-screening-older-adults
     May 24, 2022 - Morphology and visual acuity in aflibercept and ranibizumab therapy for neovascular age-related macular … Oral zinc-therapy in age-related macular degeneration: a double blind study. … Introducing anti-vascular endothelial growth factor therapies for AMD did not raise risk of myocardial … Reporting bias not detected Moderate for benefit VEGF inhibitors are considered first-line therapy … Moderate for no harm VEGF inhibitors vs sham:    VEGF inhibitors are considered first-line therapy

472. Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
     April 30, 2024 - risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy … In general, DCIS treatment, which may include surgery, radiation, and endocrine treatment, is intended … women. 27-36 Adjuvant endocrine therapy reduces the risk of cancer recurrence among individuals with … Black women are more likely to discontinue adjuvant endocrine therapy compared with White women, in part … Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women

473. Archived: Healthy Diet Promotion: Behavioral Counseling, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-promotion-behavioral-counseling-1996
     January 01, 1996 - on the patient's nutritional status, underlying medical disorders, functional status, dentition, and therapeutic … Dietary therapy slows the return of hypertension after stopping prolonged medication. … Dietary sodium restriction as adjunctive treatment of hypertension. … Treatment of spinal osteoporosis in postmenopausal women. … of High Blood Cholesterol in Adults (Adult Treatment Panel II).

474. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zmvjborz6pkcGVzgcP5nCw
     September 30, 2024 - high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy … In general, DCIS treatment, which may in- clude surgery, radiation, and endocrine treatment, is intended … women.27-36 Adju- vant endocrine therapy reduces the risk of cancer recurrence among individuals with … Black women are more likely to discontinue adjuvant endocrine therapy compared with White women, in part … Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women

475. Update on Methods: Insufficient Evidence | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/update-methods-insufficient-evidence
     March 04, 2021 - delivery in a "gold-standard" RCT may eliminate the contextual aspects of the treatment experience and … the adaptation of treatment to individual needs that underlies treatment success. … Requiring a no-treatment or usual-treatment control condition may produce insurmountable barriers to … of the clinician-patient relationship with respect to building trust and developing a collaborative therapeutic … prevents, the burdens of the therapy, the monetary costs of the therapy, and the guideline developers

476. Archived: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
     January 10, 2017 - benefits of folic acid supplementation may vary by dosage, timing relative to pregnancy, duration of therapy … Eight fair-quality case-control studies addressed dose, timing, or duration of therapy. 1 Of these 8 … No evidence was found on harms differing by duration of therapy. 1 . … vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics

477. Archived: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening-2009
     December 15, 2009 - Treatment Effective treatments, including radiation, chemotherapy (including hormonal treatment), and … Although the standard treatments women receive for ductal carcinoma in situ (DCIS) include surgical approaches … as well as radiation and hormonal therapy, considerable debate exists about the optimal treatment strategy … Discontinuation of hormone replacement therapy may be largely responsible for this observed decrease … Effect of screening and adjuvant therapy on mortality from breast cancer.

478. Archived: Final Evidence Summary: Depression in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary20/depression-in-adults-screening-2009
     December 15, 2009 - given the prevalence of use of analgesic medications (over-the-counter as well as prescription) for therapeutic … Furthermore, the available evidence base in antidepressant treatments has limitations. … Psychotherapeutic treatments for older depressed people. … Results show that additional problem-solving treatments by nurse specialists did not improve mental health … and reminiscence therapy are effective.

479. Final Recommendation Statement: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-screening
     April 30, 2024 - risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy … In general, DCIS treatment, which may include surgery, radiation, and endocrine treatment, is intended … women. 27-36 Adjuvant endocrine therapy reduces the risk of cancer recurrence among individuals with … Black women are more likely to discontinue adjuvant endocrine therapy compared with White women, in part … Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women

480. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
     September 06, 2016 - For each included study, one investigator extracted information about design, population, tests or treatments … were assessed. 12 To do this, the populations, similarities and differences in screening tests or treatments … The combination therapy was found to be noninferior to isoniazid-only treatment. … Limited usefulness of QuantiFERON-TB Gold In-Tube for monitoring anti-tuberculosis therapy. … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis